Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1988-03-21
1989-08-15
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
5142278, 5142315, 514252, 514256, 514319, 514336, 514365, 514372, 514374, 514385, 514397, 514422, 514444, 514459, 540596, 544 587, 544149, 544335, 544358, 546206, 546268, 548204, 548214, 548236, 548300, 548336, 548517, 549 60, 549292, A61K 3155, C07D40512
Patent
active
048575224
ABSTRACT:
Derivatives of pravastatin are provided which are useful in inhibiting cholesterol biosynthesis and in preparing radiolabeled compounds useful in the radioimmunoassay (RIA) of pravastatin and derivatives thereof. The pravastatin derivatives have the structure ##STR1## wherein R is hydroxy, lower alkylamine, arylamine, arylalkylamine or heterocyclic alkylamine such as histamine, tyramine, O-benzyltyramine, methyl tyrosinate as well as iodinated derivatives thereof.
REFERENCES:
patent: 4346227 (1982-08-01), Terahara et al.
patent: 4733003 (1988-03-01), Ide et al.
DiPietro Richard A.
Tu Jan-I
Turabi Noor Z.
E. R. Squibb & Sons Inc.
Rodney Burton
Schwartz Richard A.
LandOfFree
Derivatives of pravastatin for inhibiting cholesterol biosynthes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of pravastatin for inhibiting cholesterol biosynthes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of pravastatin for inhibiting cholesterol biosynthes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-121818